- We will send in 10–14 business days.
/images/books/13690013/9789403501062.jpg)
- Publisher: Kluwer Law International
- ISBN-10: 9403501065
- ISBN-13: 9789403501062
- Format: 15.6 x 23.4 x 1.1 cm, hardcover
- Language: English
- SAVE -10% with code: EXTRA
Pharmaceutical Test Data Exclusivity (e-book) (used book) | bookbook.eu
Reviews
Description
Data exclusivity gives pharmaceutical companies a limited period of time in which clinical test data are exclusive to the innovator. Internationally, however, aside from prohibition against unfair commercial use, there are no specifics as to how these data are protected; exclusivity is available on a jurisdiction-by-jurisdiction basis. This book, the only one of its kind, provides expert guidance, chapter by chapter, on test data exclusivity rights for pharmaceutical products in twenty-two major markets worldwide.
For each jurisdiction, in addition to explaining the available regulatory data protection - including both substantive and formal requirements for approvals and testing, protection of undisclosed data, confidentiality, and enforcement in practice - local experts provide detailed information and guidance on the degree to which test data exclusivity may be achieved in such areas of pharmaceutical research as the following:- infectious disease products;
- paediatrics products;
- chemical and biological products;
- agricultural products;
- animal health products;
- orphan drugs; and
- new chemical entities.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 18d.03:04:07
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Publisher: Kluwer Law International
- ISBN-10: 9403501065
- ISBN-13: 9789403501062
- Format: 15.6 x 23.4 x 1.1 cm, hardcover
- Language: English English
Data exclusivity gives pharmaceutical companies a limited period of time in which clinical test data are exclusive to the innovator. Internationally, however, aside from prohibition against unfair commercial use, there are no specifics as to how these data are protected; exclusivity is available on a jurisdiction-by-jurisdiction basis. This book, the only one of its kind, provides expert guidance, chapter by chapter, on test data exclusivity rights for pharmaceutical products in twenty-two major markets worldwide.
For each jurisdiction, in addition to explaining the available regulatory data protection - including both substantive and formal requirements for approvals and testing, protection of undisclosed data, confidentiality, and enforcement in practice - local experts provide detailed information and guidance on the degree to which test data exclusivity may be achieved in such areas of pharmaceutical research as the following:- infectious disease products;
- paediatrics products;
- chemical and biological products;
- agricultural products;
- animal health products;
- orphan drugs; and
- new chemical entities.
Reviews